Skip to main content
SpringerLink
Log in

Selecting Patients for Bone Mass Measurements: Clinical Guidelines

  • Chapter
  • First Online:
Bone Densitometry in Clinical Practice

Part of the book series: Current Clinical Practice ((CCP))

Abstract

Clinical guidelines for the selection of patients for bone mass measurements and the timing of such measurements have been carefully crafted by major medical organizations knowledgeable in osteoporosis and bone densitometry. As practice guidelines, they are intended to help the physician determine when a bone mass measurement may be useful in the care of individual patients. There are also an increasing number of risk-based assessment questionnaires that may be administered by a medical professional or self-administered by the patient to determine if a high probability of low bone density exists. Such patients would also be considered appropriate candidates for a bone mass measurement. In this chapter, the clinical guidelines from major organizations will be reviewed and compared. Risk-based assessment questionnaires will be examined in the next chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    The International Society for Clinical Densitometry was originally known as the Society for Clinical Densitometry.

  2. 2.

    Synthetic salmon calcitonin was clinically available but FDA-approved it for the treatment of osteoporosis in women who were more than 5 years postmenopausal. It was not FDA-approved for prevention.

  3. 3.

    Formerly the Osteoporosis Society of Canada.

  4. 4.

    See Chapter 10 for a discussion of global and site-specific fracture risk predictions.

  5. 5.

    The EFFO was founded in 1987. In 1998 it joined with the International Federation of Societies on Skeletal Diseases to become the International Osteoporosis Foundation.

  6. 6.

    See Chapter 2 for a discussion of the relative percentages of cortical and trabecular bone at various densitometry sites.

  7. 7.

    See Chapter 11 for a discussion of the relationship between precision and rate of change in determining the interval between measurements.

  8. 8.

    See Chapter 2 for a discussion of the effect of dystrophic calcification on the measurement of BMD in the spine.

  9. 9.

    In these guidelines, reference to “individuals” was made rather than specifically men or women.

References

  1. Miller PD, Bonnick SL, Rosen CJ. Consensus of an international panel on the clinical utility of bone mass measurement in the detection of low bone mass in the adult population. Calcif Tissue Int 1996;58:207–214.

    PubMed  CAS  Google Scholar 

  2. Lenchik L, Leib ES, Hamdy RC, Binkley NC, Miller PD, Watts NB. Executive summary International Society for Clinical Densitometry position development conference Denver, Colorado July 20–22, 2001. J Clin Densitom 2002;5 Suppl:S1–S3.

    Article  PubMed  Google Scholar 

  3. Leib ES, Lewiecki EM, Binkley N, Hamdy RC. Official positions of the International Society for Clinical Densitometry. J Clin Densitom 2004; 7(1):1–6.

    Article  PubMed  Google Scholar 

  4. Binkley N, Bilezikian JP, Kendler DL, Leib ES, Lewiecki EM, Petak SM. Official positions of the international society for clinical densitometry and executive summary of the 2005 position development conference. J Clin Densitom 2006;9(1):4–14.

    Article  PubMed  Google Scholar 

  5. Baim S, Leonard BM, Bianchi ML, et al. Official positions of the international society for clinical densitometry and executive summary of the 2007 ISCD pediatric position development conference. J Clin Densitom 2008;11:6–21.

    Article  PubMed  Google Scholar 

  6. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, et al. Bone density at various sites for the prediction of hip fractures. Lancet 1993;341:72–75.

    Article  PubMed  CAS  Google Scholar 

  7. Melton LJ, Atkinson EJ, O’Fallon WM, Wahner HW, Riggs BL. Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 1993;8:1227–1233.

    Article  PubMed  Google Scholar 

  8. Gardsell P, Johnell O, Nilsson BE, Gullberg B. Predicting various fragility fractures in women by forearm bone densitometry: a follow-up study. Calcif Tissue Int 1993;52:348–353.

    Article  PubMed  CAS  Google Scholar 

  9. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO technical report series. Geneva: WHO, 1994.

    Google Scholar 

  10. Johnston CC, Melton LJ, Lindsay R, Eddy DM. Clinical indications for bone mass measurements. A report from the scientific advisory board of the National Osteoporosis Foundation. J Bone Miner Res 1989;4(S2):1–28.

    Article  Google Scholar 

  11. National Osteoporosis Foundation. Osteoporosis: review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Osteoporos Int 1998;S4:S7–S80.

    Article  Google Scholar 

  12. National Osteoporosis Foundation. Physician’s guide to prevention and treatment of osteoporosis. Belle Meade NJ: Excerpta Medica, 1999.

    Google Scholar 

  13. Osteoporosis: Review of the evidence for prevention, diagnosis, and treatment and cost-effectiveness analysis. Executive summary. Osteoporos Int 1998;S4:S3–S6.

    Google Scholar 

  14. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. N Engl J Med 1995;332:767–773.

    Article  PubMed  CAS  Google Scholar 

  15. National Osteoporosis Foundation. Physician’s guide to prevention and treatment of osteoporosis. 1–37. 2003. Washington, DC, National Osteoporosis Foundation.

    Google Scholar 

  16. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. 1–30. 2008. Washington, DC, National Osteoporosis Foundation.

    Google Scholar 

  17. Sturtridge W, Lentle B, Hanley DA. Prevention and management of osteoporosis: consensus statements from the scientific advisory board of the Osteoporosis Society of Canada. 2. The use of bone density measurement in the diagnosis and management of osteoporosis. CMAJ 1996;155:924–929.

    PubMed  CAS  Google Scholar 

  18. Brown JP, Josse RG. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002;167:S1–S34.

    PubMed  Google Scholar 

  19. Brown JP, Fortier M. Canadian consensus conference on osteoporosis, 2006 update. JOGC 2006;172:S95–S112.

    Google Scholar 

  20. Hodgson SF, Johnston CC. AACE clinical practice guidelines for the prevention and treatment of postmenopausal osteoporosis. Endocr Pract 1996;2:155–171.

    Google Scholar 

  21. Osteoporosis Task Force. American Association of Clinical Endocrinologists 2001 medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis. Endocr Pract 2001;7:293–312.

    Google Scholar 

  22. Hodgson SF, Watts NB, Bilezikian JP et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 2003;9(6):544–564.

    PubMed  Google Scholar 

  23. Kanis J, Devogelaer J, Gennari C. Practical guide for the use of bone mineral measurements in the assessment of treatment of osteoporosis: a position paper of the European Foundation for Osteoporosis and Bone Disease. Osteoporos Int 1996;6:256–261.

    Article  PubMed  CAS  Google Scholar 

  24. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D. Guidelines for diagnosis and management of osteoporosis. Osteoporos Int 1997;7(4):390–406.

    Article  PubMed  CAS  Google Scholar 

  25. ACOG releases recommendations for bone density screening for osteoporosis. Washington, DC: American College of Obstetricians and Gynecologists, 2002. (Accessed March 26, 2002, at http://www.acog.org/from_home/publications/press_releases/nr02-28-02-1.htm)

  26. Management of postmenopausal osteoporosis: position statement of The North American Menopause Society. Menopause 2002;9:84–101.

    Google Scholar 

  27. Kanis JA, Gluer C-C. An update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis Foundation. Osteoporos Int 2000;11:192–202.

    Article  PubMed  CAS  Google Scholar 

  28. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society. Menopause 2006;13:340–367.

    Google Scholar 

  29. US Preventive Services Task Force. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 2002;137:526–528.

    Google Scholar 

  30. Nelson HD, Helfand M, Woolf SH, Allan JD. Screening for postmenopausal osteoporosis: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;137:529–541.

    PubMed  Google Scholar 

  31. The New US Preventive Services Task Force. AHRQ Pub. No. 00-P046. Washington, DC: AHQR, February 2002. (Accessed October 19, 2002, at http://www.preventiveservices.ahrq.gov)

  32. Genant HK, Cooper C, Poor G, et al. Interim report and recommendations of the World Health Organization Task-Force for osteoporosis. Osteoporos Int 1999;10:259–264.

    Article  PubMed  CAS  Google Scholar 

  33. WHO. Prevention and management of osteoporosis. [921], 1–192. 2003. Geneva, WHO. WHO Technical Report Series.

    Google Scholar 

  34. Melton LJ, Atkinson EJ, O’Connor MK, O’Fallon WM, Riggs BL. Bone density and fracture risk in men. J Bone Miner Res 1998;13:1915–1923.

    Article  PubMed  Google Scholar 

  35. Seeman E, Melton LJ, O’Fallon WM, Riggs BL. Risk factors for spinal osteoporosis in men. Am J Med 1983;75:977–983.

    Article  PubMed  CAS  Google Scholar 

  36. Jackson JA, Kleerekoper M. Osteoporosis in men: diagnosis, pathophysiology, and prevention. Medicine 1990;69:137–152.

    Article  PubMed  CAS  Google Scholar 

  37. Cauley JA, Smuda JM. Risk factors for fractures in men. In: Orwoll ES, ed. Osteoporosis in men. London, England: Academic Press, 1999:363–393.

    Chapter  Google Scholar 

  38. Orwoll E. Perspective: assessing bone density in men. J Bone Miner Res 2000;15:1867–1870.

    Article  PubMed  CAS  Google Scholar 

  39. Binkley NC, Schmeer P, Wasnich RD, Lenchik L. What are the criteria by which a densitometric diagnosis of osteoporosis can be made in males and non-Caucasians? J Clin Densitom 2002;5:S19–S27.

    Article  PubMed  Google Scholar 

  40. Qaseem A, Snow V, Shekelle P, et al. Screening for osteoporosis in men: a clinical practice guideline from the American College of Physician. Ann Intern Med 2008; 148:680–684.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Research Center of North Texas, 2921, Country Club Road, #101, Denton, TX, USA

    Sydney Lou Bonnick MD, FACP

Authors
  1. Sydney Lou Bonnick MD, FACP
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sydney Lou Bonnick MD, FACP .

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Bonnick, S.L. (2010). Selecting Patients for Bone Mass Measurements: Clinical Guidelines. In: Bone Densitometry in Clinical Practice. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-499-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-499-9_7

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60327-498-2

  • Online ISBN: 978-1-60327-499-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation